(Q51486964)

English

Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study.

scientific article published in November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

author name string

Issam Zineh

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

Gregory J Welder

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

Amy E DeBella

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

Christopher B Arant

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

Timothy R Wessel

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

Richard S Schofield

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

language of work or name

0 references

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

26

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

11

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

1572-1577

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

CD40 signaling and plaque instability

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

CD40-CD40L interactions in atherosclerosis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Soluble CD40L and cardiovascular risk in women

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Which white blood cell subtypes predict increased cardiovascular risk?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.11.1572

21 January 2018

Identifiers

10.1592/PHCO.26.11.1572

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17064201

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51486964&oldid=1009477674"